Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-08794-w, published online 23 March 2022
Mohammed Wael Mohamed was omitted from the author list in the original version of this Article.
The Author Contributions section now reads:
“N.K.: data analysis, interpretation and preparation of the manuscript; D.A., A.A., F.A., M.A.F., F.A., F.A., S.S., A.A., Z.A., S.O. S.A. & M.M.: conception and design, data collection, manuscript review; S.S., N.K. & S.L.A.: writing and manuscript review; M.A.Q.: conception and design of the study and manuscript review.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
AlQahtani, M., Kumar, N., Aljawder, D. et al. Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease. Sci Rep 12, 16052 (2022). https://doi.org/10.1038/s41598-022-20899-w
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-022-20899-w
